1. Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders
2. A regulatory framework review of Schedule I psychedelics in the United States;Herkenham K;J Am Coll Clin Pharm,2023
3. Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics
4. Psychedelic Pharmacists Association.Our mission. Available from:https://psychedelicpharmacist.org/. Accessed 31 Aug 2023
5. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER).Psychedelic drugs: considerations for clinical investigations guidance for industry. Available from:https://www.fda.gov/regulatory‐information/search‐fda‐guidance‐documents/psychedelic‐drugs‐considerations‐clinical‐investigations. Accessed 31 Aug 2023